SCHEMBL202829

SCHEMBL202829

Cc1cc2nn[nH]c2cc1Cl

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN2D O15399 1/20 0.47
GRIN3B O60391 1/20 0.47
GRIN1 Q05586 1/20 0.47
GRIN2A Q12879 1/20 0.47
GRIN2B Q13224 1/20 0.47
GRIN2C Q14957 1/20 0.47
GRIN3A Q8TCU5 1/20 0.47
PDE3B Q13370 1/20 0.39
PDE3A Q14432 1/20 0.39
CD44 P16070 1/20 0.35
AMY1A P0DUB6 1/20 0.33
FABP6 P51161 1/20 0.33
MEN1 O00255 2/20 0.32
MAPT P10636 2/20 0.32
KMT2A Q03164 2/20 0.32
ATM Q13315 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CACNA1B Q00975 1/20 0.32
APBA1 Q02410 1/20 0.32
MCL1 Q07820 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30036958 1.00 GRIN2D (0.47) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL1021150 0.94 GRIN2D (0.44) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL271074 0.85 FABP6 (0.43) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Water SCHEMBL29778699 0.83 FABP6 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL205009 0.83 MAPK13 (0.48) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Water SCHEMBL2493413 0.83 FABP6 (0.42) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Water SCHEMBL11187894 0.81 FABP6 (0.41) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
Water SCHEMBL11194637 0.79 FABP6 (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL7854822 0.78 KEAP1 (0.39) GRIN2DGRIN3BGRIN1GRIN2AGRIN2B
SCHEMBL18331057 0.76 FABP6 (0.33) AMY1AFABP6MEN1MAPTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1089982-B1 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BETZDEARBORN INC (US) 2006-08-30 EP claimed
EP-1089982-A4 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BETZDEARBORN INC (US) 2005-04-06 EP claimed
CN-1184210-C Methods of inhibiting corrosion using isomers of chloro-methylbenzotrazole BETZDEARBORN INC (US) 2005-01-12 CN claimed
CN-1306517-A Methods of inhibiting corrosion using isomers of chloro-methylbenzotrazole BETZDEARBORN INC (US) 2001-08-01 CN claimed
EP-1089982-A1 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BetzDearborn Inc (US) 2001-04-11 EP claimed
WO-1999067222-A1 METHODS OF INHIBITING CORROSION USING ISOMERS OF CHLORO-METHYLBENZOTRIAZOLE BETZDEARBORN INC. (US) 1999-12-29 WO claimed
US-5968408-A ODORLESS BETZDEARBORN INC. (US) 1999-10-19 US claimed
US-20240174583-A1 PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES DOW TECHNOLOGY INVESTMENTS LLC (US) 2024-05-30 US disclosed
EP-4347544-A1 PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES Dow Technology Investments LLC (US) 2024-04-10 EP disclosed
CN-117242047-A Process for the vapor phase hydrogenation of aldehydes 陶氏技术投资有限责任公司 2023-12-15 CN disclosed
US-10899721-B2 Tetrazole based corrosion inhibitors ECOLAB USA INC. (US) 2021-01-26 US disclosed
EP-3428148-B1 ARYLOAZOL-2-YL CYANOETHYLAMINO COMPOUNDS, METHOD OF MAKING AND METHOD OF USING THEREOF BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC (US) 2020-07-08 EP disclosed
EP-3077573-B1 TETRAZOLE BASED CORROSION INHIBITORS ECOLAB USA INC (US) 2019-07-10 EP disclosed
US-5968408-A ODORLESS BETZDEARBORN INC. (US) 1999-10-19 US disclosed
CN-1220652-A improved metal-ligand complex catalyzed processes UNION CARBIDE CHEM PLASTIC (US) 1999-06-23 CN disclosed
EP-0873292-A1 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-10-28 EP disclosed
US-5731472-A HETEROCYCLIC NITROGEN COMPOUNDS UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1998-03-24 US disclosed
WO-1997020798-A1 IMPROVED METAL-LIGAND COMPLEX CATALYZED PROCESSES UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) 1997-06-12 WO disclosed
US-4546069-A BLEACH BATHS OF ACID, IODIDE, NITRO COMPOUND, ANTIOXIDANT, BLEACH CATALYST, DEVELOPER AND/OR BENZOTRIAZOLE; HIGH -SPEED AUTOMATIC PRI CIBA-GEIGY AG (CH) 1985-10-08 US disclosed
EP-0133163-A2 Method of processing photographic silver dye-bleaching materials CIBA-GEIGY AG (CH) 1985-02-13 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10899721-B2 Tetrazole based corrosion inhibitors CA1, ATR, AAAS GRIN2D 42/4885GRIN3B 43/4885GRIN1 9/4885
US-20240174583-A1 PROCESSES FOR THE VAPOR PHASE HYDROGENATION OF ALDEHYDES ADH1C, ADH5, ALDH2 GRIN2D 1979/4885GRIN3B 2083/4885GRIN1 2427/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.